A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China-Reference-Cited by-同舟云学术

A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China

Published:2017-03-20 Issue:4 Volume:39 Page:392-401
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int. Jnl. Lab. Hem.

Author:

Qin X.¹,Tang G.²,Gao R.¹,Guo Z.¹,Liu Z.¹,Yu S.¹,Chen M.³,Tao Z.⁴,Li S.⁵,Liu M.⁶,Wang L.⁷,Hou L.¹,Xia L.¹,Cheng X.¹,Han J.¹,Qiu L.¹^ORCID

Affiliation:

1. Department of Clinical Laboratory; Peking Union Medical College Hospital; Peking Union Medical College & Chinese Academy of Medical Science; Beijing China

2. Department of Cardiology; Beijing Hospital of the Ministry of Health; Beijing China

3. Department of Clinical Laboratory; Third Affiliated Hospital of Third Military Medical University; Chongqing China

4. Department of Clinical Laboratory; The Second Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou China

5. Department of Clinical Laboratory; The First Affiliated Hospital of Dalian Medical University; Dalian China

6. Department of Clinical Laboratory; The First Affiliated Hospital; Sun Yat-sen University; Guangzhou China

7. Department of Clinical Laboratory; Xinjiang Medical University; Urumuqi China

Funder

National clinical key construction project

Peking Union Medical College Hospital

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijlh.12639/fullpdf

Reference22 articles.

1. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma;Chen;BMC Gastroenterol,2011

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma;Liebman;N Engl J Med,1984

4. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients;Marrero;Hepatology,2003

5. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma;Tanaka;Hepatogastroenterology,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical application of PIVKA‐II in hepatocellular carcinoma and chronic liver diseases: A multi‐center study in China;Journal of Clinical Laboratory Analysis;2021-09-30

2. Analytical performances and biological variation of PIVKA-II (des-y-carboxy-prothrombin) in European healthy adults;Clinica Chimica Acta;2020-10

3. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy;Liver International;2020-05-23

4. Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: Sub-analysis from a prospective multicenter study;Clinical Biochemistry;2018-04